Vencorex expands its Tolonate HDI derivatives capacity into Asia
Vencorex is expanding its global capacity for Tolonate™ HDI derivatives by establishing a new production unit in Thailand. The new plant will be ready to serve the Asian market in 2015.
“We want to strengthen our global position, and our presence in Asia will be a significant
stepping stone, among others” says CEO Magnus Lanner. “This new asset in Asia, with an annual capacity of 12,000 tons per year and our own state-of-the-art technology, will serve this expansion, helping the industry in Asia to provide very high quality offerings and technology. Thailand is a strategic location and will provide Vencorex with a competitive advantage in the region.”
“Asia is fast growing and this new capacity will allow us to effectively participate in this
rapidly expanding market. We will improve our level of service through these dedicated
resources within the region. The new plant in Thailand will provide us with an industrial
footprint for HDI and derivatives: in addition the markets served by Pont-de-Claix in France and Freeport in the USA”, says Sutin Chamulitrat, Vice President, Marketing & Sales.
With this investment in Aliphatic Isocyanates derivatives production in Asia, Vencorex will
have global facilities on 3 continents. Vencorex has strong ambition to be your core
partner as a solution provider in this business.
Other news from the department manufacturing
